SEVORANE LIQUID FOR INHALATION

Sevorane Liquid For Inhalation Adverse Events Reported to the FDA Over Time

How are Sevorane Liquid For Inhalation adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Sevorane Liquid For Inhalation, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Sevorane Liquid For Inhalation is flagged as the suspect drug causing the adverse event.

Most Common Sevorane Liquid For Inhalation Adverse Events Reported to the FDA

What are the most common Sevorane Liquid For Inhalation adverse events reported to the FDA?

Coma	25 (2.48%)
Overdose	20 (1.98%)
Cardiac Arrest	18 (1.78%)
Depressed Level Of Consciousness	18 (1.78%)
Hypokinesia	17 (1.68%)
Cytolytic Hepatitis	16 (1.59%)
Somnolence	15 (1.49%)
Anaesthetic Complication	14 (1.39%)
Bradycardia	14 (1.39%)
Alanine Aminotransferase Increased	13 (1.29%)
Hyperthermia Malignant	13 (1.29%)
	Show More
Dystonia	12 (1.19%)
Hepatic Failure	12 (1.19%)
Oxygen Saturation Decreased	12 (1.19%)
Pyrexia	12 (1.19%)
Hypotonia	11 (1.09%)
Rhabdomyolysis	10 (.99%)
Aspartate Aminotransferase Increase...	9 (.89%)
Dyskinesia	9 (.89%)
Gamma-glutamyltransferase Increased	9 (.89%)
Hypotension	9 (.89%)
Metabolic Acidosis	9 (.89%)
Pulse Absent	9 (.89%)
Anaesthetic Complication Neurologic...	8 (.79%)
Anaphylactoid Shock	8 (.79%)
Aphasia	8 (.79%)
Communication Disorder	8 (.79%)
Dysphagia	8 (.79%)
Fatigue	8 (.79%)
Hyperhidrosis	8 (.79%)
Muscle Rigidity	8 (.79%)
Muscle Spasticity	8 (.79%)
Post Procedural Complication	8 (.79%)
Tachycardia	8 (.79%)
Blood Creatine Phosphokinase Increa...	7 (.69%)
Brain Hypoxia	7 (.69%)
Cyanosis	7 (.69%)
Muscle Spasms	7 (.69%)
Oedema	7 (.69%)
Pulmonary Oedema	7 (.69%)
Anaphylactic Shock	6 (.59%)
Arrhythmia	6 (.59%)
Blood Lactic Acid Increased	6 (.59%)
Blood Pressure Decreased	6 (.59%)
Brain Stem Syndrome	6 (.59%)
Disseminated Intravascular Coagulat...	6 (.59%)
Dysarthria	6 (.59%)
Erythema	6 (.59%)
Haematemesis	6 (.59%)
Hypersensitivity	6 (.59%)
Hyperthermia	6 (.59%)
Jaundice	6 (.59%)
Nystagmus	6 (.59%)
Respiration Abnormal	6 (.59%)
Vomiting	6 (.59%)
Acidosis	5 (.5%)
Blood Lactate Dehydrogenase Increas...	5 (.5%)
Cardiac Failure	5 (.5%)
Convulsion	5 (.5%)
Hepatic Necrosis	5 (.5%)
Hyperglycaemia	5 (.5%)
Hypoventilation	5 (.5%)
Liver Disorder	5 (.5%)
Nausea	5 (.5%)
Renal Failure Acute	5 (.5%)
Shock	5 (.5%)
Ventricular Fibrillation	5 (.5%)
Apnoea	4 (.4%)
Ataxia	4 (.4%)
Atrial Fibrillation	4 (.4%)
Bronchospasm	4 (.4%)
Cardiopulmonary Failure	4 (.4%)
Coagulation Factor Decreased	4 (.4%)
Condition Aggravated	4 (.4%)
Delayed Recovery From Anaesthesia	4 (.4%)
Delirium	4 (.4%)
Depressed Mood	4 (.4%)
Dizziness	4 (.4%)
Drug Ineffective	4 (.4%)
Drug Toxicity	4 (.4%)
Haemoptysis	4 (.4%)
Hepatic Enzyme Increased	4 (.4%)
Hepatitis	4 (.4%)
Hepatorenal Syndrome	4 (.4%)
Hypertonia	4 (.4%)
Hypoglycaemia	4 (.4%)
Hyponatraemia	4 (.4%)
Lactic Acidosis	4 (.4%)
Liver Function Test Abnormal	4 (.4%)
Malaise	4 (.4%)
Mutism	4 (.4%)
Myoglobinuria	4 (.4%)
Pain	4 (.4%)
Pancreatitis Acute	4 (.4%)
Paraesthesia	4 (.4%)
Poor Quality Sleep	4 (.4%)
Post Concussion Syndrome	4 (.4%)
Screaming	4 (.4%)
Speech Disorder	4 (.4%)
Status Epilepticus	4 (.4%)
Ventricular Tachycardia	4 (.4%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Sevorane Liquid For Inhalation, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sevorane Liquid For Inhalation is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Sevorane Liquid For Inhalation

What are the most common Sevorane Liquid For Inhalation adverse events reported to the FDA?

Neurological	113 (11.2%)
Cardiac Arrhythmias	71 (7.04%)
Hepatic And Hepatobiliary	61 (6.05%)
Respiratory	46 (4.56%)
Procedural And Device Related Injur...	45 (4.46%)
Hepatobiliary	42 (4.16%)
Movement Disorders	39 (3.87%)
Cardiac And Vascular Investigations	38 (3.77%)
Body Temperature Conditions	32 (3.17%)
Epidermal And Dermal Conditions	27 (2.68%)
Muscle	27 (2.68%)
	Show More
Neuromuscular	26 (2.58%)
Metabolic, Nutritional And Blood Ga...	25 (2.48%)
Medication Errors	23 (2.28%)
Allergic Conditions	22 (2.18%)
Gastrointestinal Signs	22 (2.18%)
Acid-base	18 (1.78%)
Decreased And Nonspecific Blood Pre...	17 (1.68%)
Communication Disorders	16 (1.59%)
Enzyme	14 (1.39%)
Lower Respiratory Tract Disorders	13 (1.29%)
Seizures	13 (1.29%)
Heart Failures	12 (1.19%)
Hematology Investigations	11 (1.09%)
Skin Appendage Conditions	11 (1.09%)
Coagulopathies And Bleeding Diathes...	9 (.89%)
Glucose Metabolism Disorders	9 (.89%)
Bronchial Disorders	8 (.79%)
Cardiac Disorder Signs	7 (.69%)
Infections - Pathogen Unspecified	7 (.69%)
Physical Examination Topics	7 (.69%)
Renal Disorders	7 (.69%)
Chemical Injury And Poisoning	6 (.59%)
Gastrointestinal Hemorrhages	6 (.59%)
Gastrointestinal Stenosis And Obstr...	6 (.59%)
Injuries	6 (.59%)
Urinary Tract Signs	6 (.59%)
Encephalopathies	5 (.5%)
Therapeutic And Nontherapeutic Effe...	5 (.5%)
Bacterial Infectious	4 (.4%)
Deliria	4 (.4%)
Depressed Mood Disorders	4 (.4%)
Electrolyte And Fluid Balance Condi...	4 (.4%)
Exocrine Pancreas Conditions	4 (.4%)
Musculoskeletal And Connective Tiss...	4 (.4%)
Psychiatric And Behavioural Symptom...	4 (.4%)
Sleep Disturbances	4 (.4%)
Gastrointestinal Conditions	3 (.3%)
Mycoplasmal Infectious	3 (.3%)
Peritoneal And Retroperitoneal Cond...	3 (.3%)
Renal And Urinary Tract Investigati...	3 (.3%)
Tongue Conditions	3 (.3%)
White Blood Cell	3 (.3%)
Angiedema And Urticaria	2 (.2%)
Cranial Nerve Disorders	2 (.2%)
Gallbladder	2 (.2%)
Increased Intracranial Pressure And...	2 (.2%)
Injuries By Physical Agents	2 (.2%)
Mood Disorders	2 (.2%)
Myocardial	2 (.2%)
Neonatal And Perinatal Conditions	2 (.2%)
Platelet	2 (.2%)
Spleen, Lymphatic And Reticulendoth...	2 (.2%)
Structural Brain	2 (.2%)
Urolithiases	2 (.2%)
Administration Site Reactions	1 (.1%)
Anemias Nonhemolytic And Marrow Dep...	1 (.1%)
Anxiety Disorders	1 (.1%)
Coronary Artery	1 (.1%)
Endocrine Disorders Congenital	1 (.1%)
Endocrine Neoplasms Malignant And U...	1 (.1%)
Fungal Infectious	1 (.1%)
Microbiology And Serology	1 (.1%)
Neonatal Respiratory	1 (.1%)
Oral Soft Tissue Conditions	1 (.1%)
Pleural	1 (.1%)
Protein And Chemistry Analyses	1 (.1%)
Respiratory And Pulmonary Investiga...	1 (.1%)
Salivary Gland Conditions	1 (.1%)
Therapeutic Procedures And Supporti...	1 (.1%)
Vascular	1 (.1%)
Viral Infectious	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Sevorane Liquid For Inhalation, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sevorane Liquid For Inhalation is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.